Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Language
Publication year range
1.
Exp Oncol ; 37(1): 48-52, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25804232

ABSTRACT

AIM: To evaluate the association between the presence of CD8 and CD45RO T lymphocytes in bone marrow (BM), disseminated tumor cells (DTCs), tumor hypoxia and their impact on disease outcome. MATERIAL AND METHODS: 91 naïve gastric cancer (GC) patients were enrolled into the study. DTCs, CD8- and CD45RO-positive T lymphocytes in BM were detected using immunocytochemistry. All patients were thoroughly informed about the study that was approved by the local ethics committee. Statistical analyses were done using NCSS2000/PASS2000 and Prism, version 4.03 software packages. RESULTS: It was detected that 80.5 and 81.3% of patients had CD8- and CD45RO-positive T cells in BM, respectively. When DTCs were detected in BM, the number of patients with CD8-and CD45RO-positive T cells in BM were 86.1 and 84.4%, respectively. It was also determined that the number of patients with DTCs in BM with categories M0 and M1 and with CD8- and CD45RO-positive T cells in BM were 86.2 and 85.7%, 85.7 and 80.0%, respectively. The association between DTCs in BM and presence of CD8 and CD45RO T cells lymphocytes in BM was not found. At the same time it was shown the association between presence of CD8 and CD45RO T lymphocytes and survival. The presence of CD8- and CD45RO-positive T cells in BM were accompanied with significantly longer overall survival of patients compared to that of patients without CD8- and CD45RO-positive T cells in BM. CONCLUSION: Patients with the presence of CD8- and CD45RO-positive T cells in BM demonstrated better survival of GC patients than those with the absence of these cells in BM. It may be suggested that tumor cells in BM are controlled in a dormant state by T cells in BM, in particular by CD8-positive T cells.


Subject(s)
Bone Marrow/pathology , CD8 Antigens/analysis , Hypoxia/complications , Leukocyte Common Antigens/analysis , Stomach Neoplasms/complications , Stomach Neoplasms/pathology , T-Lymphocytes/pathology , Adult , Aged , Aged, 80 and over , CD8-Positive T-Lymphocytes/pathology , Female , Humans , Male , Middle Aged , Neoplasm Invasiveness/pathology , Stomach/pathology , Survival Analysis
2.
Exp Oncol ; 36(4): 271-5, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25537223

ABSTRACT

UNLABELLED: The aim of this study was to detect the hypoxic status in adjacent histologically uninvolved gastric mucosa in gastric cancer (GC) patients. PATIENTS AND METHODS: 50 naïve patients with primary GC, and one patient with stomach ulcer (gastric mucosa was used as control) were enrolled into the study. The tumor and mucosa samples of stomach (without muscularis and serosa layers) in patients with GC were obtained immediately after operation. Assessment of the hypoxia level has been provided using (31)P NMR spectroscopy in tissue perchloric acid extracts. Mucosa was examined by convenient histological method. Obtained results were analyzed statistically. RESULTS: It was shown that gastric mucosa in 52% of patients with GC is under different levels of hypoxia, among them 23% of mucosa is under severe hypoxia (PME/Pi < 1.0) with average mean of PME/Pi 0.89 ± 0.04. It was revealed that there are definite associations between the hypoxia in mucosa tissue and pT as well as pN categories and G grade and stage of disease but not with M category. Overall survival of patients with gastric mucosa characterized by severe and mild hypoxia was significantly poorer as compared to that of patients with gastric mucosa with satisfactory oxygenation (p = 0.0035). CONCLUSION: Gastric mucosa uninvolved in tumor process is characterized by hypoxia in 52% of GC patients; severe hypoxia of mucosa was detected in 23% of patients having hypoxic mucosa. It was suggested that biochemical alterations in tissue surrounding tumor node may precede morphological ones.


Subject(s)
Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Hypoxia/metabolism , Stomach Neoplasms/metabolism , Stomach Neoplasms/pathology , Adult , Aged , Female , Humans , Male , Middle Aged , Neoplasm Grading , Neoplasm Metastasis , Neoplasm Staging , Nuclear Magnetic Resonance, Biomolecular , Oxygen Consumption , Stomach Neoplasms/mortality
3.
Exp Oncol ; 34(4): 336-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23302992

ABSTRACT

OBJECTIVES: To evaluate the ability of manganese perovskite nanoparticles (lanthanum-strontium manganite) to heat the tumor tissue in vivo under action of external alternating magnetic field. MATERIALS AND METHODS: The magnetic fluid on the basis of nanoparticles of perovskite manganite was tested in the heating experiments using of alternating magnetic field of frequency 300 kHz and amplitude 7.7 kA/m. Guerin carcinoma was transplanted into the muscle of rat. Magnetic fluid was injected intramuscularly or intratumorally. Temperature was measured by copper-constantan thermocouple. RESULTS: Temperature of magnetic fluid was increased by 56 °C for 10 min of alternating magnetic field action. Administration of magnetic fluid into the muscle followed by alternating magnetic field resulted in the elevation of muscle temperature by 8 °C after 30 min post injection. Temperature of the tumor injected with magnetic fluid and treated by alternating magnetic field was increased by 13.6 °C on the 30 min of combined influence. CONCLUSION: In vivo study with rat tissue has demonstrated that magnetic fluid of manganite perovskite injected in the tumor increases the tumor temperature under an alternating magnetic field. Obtained results emphasize that magnetic fluid of manganite perovskite can be considered as effective inducer of tumor hyperthermia.


Subject(s)
Antineoplastic Agents/pharmacology , Hyperthermia, Induced/methods , Manganese Compounds/pharmacology , Nanoparticles , Neoplasms, Experimental/therapy , Animals , Calcium Compounds/pharmacology , Female , Lanthanum/pharmacology , Magnetic Field Therapy/methods , Manganese/pharmacology , Oxides/pharmacology , Rats , Strontium/pharmacology , Titanium/pharmacology
4.
Exp Oncol ; 33(3): 130-5, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21956464

ABSTRACT

OBJECTIVES: To synthesize magnetic particles of lanthanum-strontium manganite, prepare the magnetic fluid (MF), evaluate the generation of heat by particles and determine their common toxiсity. METHODS: Nanoparticles based on the solid solutions of lanthanum-strontium manganite (La(1-x)Sr(x)MnO(3)) have been synthesized by a sol-gel method. Conventional methods of experimental oncology were used. RESULTS: Nanoparticles of ferromagnetic materials on the basis of solid solutions of lanthanum strontium manganite by sol-gel method were synthesized. It was shown the possibility to regulate the aggregate form of particles that are formed during the synthesis. Magnetic fluid based on the synthesized nanoparticles and water solutions of agarose have been produced. It was shown the possibility to heat this magnetic fluid up to 42-45 °Ð¡ in externally applied alternating magnetic field (AMF) operated at 100-400 kHz. It was determined that under long-term influence of AMF nanofluid is heated up to temperature which is not over that of magnetic phase transition. It was detected that magnetic powder as well as fluid have not displayed acute toxicity or side effects (intraperitoneal or intratumoral administration) in animals either intact or with transplanted tumors. CONCLUSIONS: Possibility of synthesized magnetic fluid to generate heat in externally applied AMF as well as lack of side effects allow to consider its as a potential mean for tumor hyperthermia (HT).


Subject(s)
Hyperthermia, Induced/methods , Metal Nanoparticles , Neoplasms, Experimental/therapy , Animals , Female , Hot Temperature , Lanthanum , Magnetic Fields , Male , Manganese Compounds , Metal Nanoparticles/toxicity , Mice , Mice, Inbred C57BL , Rats , Strontium
5.
Clin. transl. oncol. (Print) ; 13(2): 133-138, feb. 2011. tab, ilus
Article in English | IBECS | ID: ibc-124425

ABSTRACT

INTRODUCTION: Hypoxia is a key feature of the microenvironment of cancer cells actively participating in tumour progression. Our study was aimed to evaluate the impact of hypoxia and hypoxia-associated factors on tumour progression and survival of patients with gastric cancer. MATERIAL AND METHODS: One hundred and five resected specimens were used. The level of tumour hypoxia was evaluated using (31)P NMR spectroscopy, CD68 (tumour-associated macrophages), CD34 (microvessel density, MVD) and VEGF expression, immunohistochemistry, MMP-2 and MMP-9 activity, zymography. Statistical analysis was conducted using Pearson's test, Kaplan-Meier survival analysis, log-rank test and Cox proportional hazards model. RESULTS: Intratumoral hypoxia level has been significantly correlated with VEGF expression, TAM number and total protease activity. The overall survival rate of patients with strong tumour hypoxia, high level of MVD, VEGF expression, TAM and MMP activity was significantly lower than that of the patients without the mentioned tumour characteristics. CONCLUSIONS: The hypoxia-associated signalling that is activated in tumours promotes tumour progression through the recruitment of macrophages, remodelling of extracellular matrix and neoangiogenesi (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Hypoxia/complications , Hypoxia/diagnosis , Macrophages/pathology , Matrix Metalloproteinases/metabolism , Microvessels/pathology , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Vascular Endothelial Growth Factor A/metabolism , Adenocarcinoma/blood supply , Adenocarcinoma/metabolism , Hypoxia/metabolism , Immunohistochemistry/methods , Stomach Neoplasms/blood supply , Stomach Neoplasms/metabolism , Survival Rate , Cell Count/methods
6.
Exp Oncol ; 29(3): 207-11, 2007 Sep.
Article in English | MEDLINE | ID: mdl-18004246

ABSTRACT

AIM: To evaluate the hypoxia level and some indices of Lewis lung carcinoma energy metabolism by means of 31P NMR spectroscopy in perchloric acid (PCA) tissue extracts during growth of primary tumor and metastasis. MATERIALS AND METHODS: C57Bl/6 mice-bearing Lewis lung carcinoma were used in this study. Tumor energy metabolism was studied by 31P NMR spectroscopy and the metabolic NMR ratios were used as parameters for metabolic status and hypoxia level. RESULTS: It was shown that growth of primary tumor is accompanied with increase of Pi/PCr, Pi/betaNTP and PME/betaNTP ratios that reflect drop of tumor energy status and oxygenation level in tumor tissue. These changes in relevant metabolic ratios correlate with enlargement of primary tumor volume (r=0.87, p=0.0045; r=0.90, p=0.0012; r=0.764, p=0.05, respectively) as well as with the number of lung metastases (r(s)=0.761, p=0.028; r(s)=0.86, p=0.0049; r(s)=0.77, p=0.040, respectively). CONCLUSION: In present study it was shown that 31P NMR spectroscopy of PCA tumor tissue extracts may be used as reliable method for the assessment of the level of oxygenation as well as changes in energy metabolism in the experimental tumors. It may be helpful to evaluate the energy status of human tumors by investigation both of biopsy and surgical specimens. Hypoxia and hypoxia-associated metabolic events in primary tumor are linked with malignant progression, in particular metastasis.


Subject(s)
Carcinoma, Lewis Lung/physiopathology , Energy Metabolism , Magnetic Resonance Spectroscopy , Animals , Cell Hypoxia/physiology , Disease Progression , Mice , Mice, Inbred C57BL , Phosphorus Isotopes
7.
Exp Oncol ; 27(3): 202-5, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16244581

ABSTRACT

AIM: To investigate the relationship between tumor hypoxia in vivo, activity of matrix metalloproteinases (MMPs), and metastatic potential of tumor. MATERIALS AND METHODS: Lewis lung carcinoma (3LL) was used in this study. Total activity of MMP-2 and -9 in tumor was measured biochemically, tumor hypoxia level was assessed by (31)P NMR spectroscopy in tissue perchloric extracts. RESULTS: It was determined that hypoxia level in primary tumor has been concomitantly increasing along with tumor growth and correlated with metastasis level in lung. The positive correlation between hypoxia level and activities of MMP-2 and MMP-9 in primary tumor was registered. Moreover, the activity of MMP-2 and -9 in 3LL (primary tumor) directly correlates with metastasis level in lung. CONCLUSION: This study demonstrated that the growth of primary tumor is distinctly accompanied by an increase of tumor hypoxia level which positively correlates both with the activity of MMP-2 and -9 in primary tumor and metastatic efficiency.


Subject(s)
Carcinoma, Lewis Lung/physiopathology , Cell Hypoxia , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Neoplasm Metastasis/physiopathology , Animals , Female , Magnetic Resonance Spectroscopy , Mice , Mice, Inbred C57BL
SELECTION OF CITATIONS
SEARCH DETAIL
...